
The heterogeneity of post- stroke cognitive impairments is reflected
in the range of severity and variety of domain-specific and
domain-general degeneration. In addition, stroke survivors may have
visual, communication, and/or motor impairments impacting the way we
assess cognitive function. Stroke-specific cognitive screening is
required, though no single cognitive screening tool can appropriately
capture both domain-specific and general cognitive impairment at the
correct level of complexity for every single person. I will combine
validated stroke-specific cognitive screening tests in a computerised
multi-stage format which adapts to the nature and severity of the
cognitive impairments under assessment. I will co-produce the Multistage
Cognitive Screening computer-tablet app (MSC-Stroke) and reporting, with
allied health professionals and stroke survivors. I will determine 1)
the equivalency of the MSC-Stroke implemented tests with their
paper-based versions, 2) the association between functional outcomes and
MCS-Stroke performance, 3) and validate the internal structure of the
MSC-Stroke using factor analysis. 300 stroke survivors across the
stroke-pathway will be recruited. The outcome of the fellowship will be
a co-produced multi-staged cognitive screening app adjustable for most
stroke survivors across the stroke pathway. Further research will be
needed to ultimately seek medical device regulation for implementation
in clinical practice.
- Status: Active.
This project will evaluate and prepare the Oxford Cognitive Screen-Plus (OCS-Plus) for clinical use following Traumatic Brain Injury (TBI). The OCS-Plus is a tablet-based cognitive screening app already available on the Apple and Google Play Stores, with over 2,000 downloads and a secure data-upload facility for research use. Building on the success of the paper-based Oxford Cognitive Screen (now implemented in 179 NHS stroke units), the OCS-Plus provides brief, domain-specific, and sensitive digital screening for cognitive impairment. The innovation addresses a clear unmet need: there is currently no standardised cognitive screening pathway for TBI in the NHS. Early care often focuses on physical recovery, and cognitive problems are frequently missed until much later, when they already limit independence and participation in rehabilitation. The OCS-Plus offers an evidence-based, scalable, and user-friendly tool that can support early detection, triage, and monitoring across acute and community services. End users include NHS clinicians, neuropsychology and rehabilitation teams, and digital-health providers seeking validated cognitive screening tools. We are recruiting 50 persons with TBI to complete the OCS-Plus as well as several other neuropsychological assessment to pilot the diagnostic accuracy, feasibility, and acceptibility of the OCS-Plus in TBI. - Status: Active recruitment
Funded by the commercial company Brain Stimulation AB (based in Sweden), I was employed as a post-doc on and then consulted on a multi-site international trial psychometrically validating a commercial computer tablet version of the OCS. The study covers stroke wards (acute and rehab) in Sweden, Italy, and the UK. We aimed to collect data for 150 stroke survivors and 100 neurologically healthy controls. We compared the paper OCS to the DiSTRO-OCS to establish equivillance. Awaiting final results and publication. - Status: Analyses finished. (Oct 2025)
As part of a part-time role with the commercial company Peter Pease Business Psychology, I was leading the psychometric development and validation of a project generating a new personality questionnaire for employee learning and development. I was employed for nearly 18 months for this role which was remote and we produce both a long and short form of the questionnaire which was psychometrically sound. - Status: Project completed Sept 2024.